These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 19050173)
1. Old and new pharmacology: positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B/C) receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']di pyrrole-1(2H)-carboxamide). Dunlop J; Lock T; Jow B; Sitzia F; Grauer S; Jow F; Kramer A; Bowlby MR; Randall A; Kowal D; Gilbert A; Comery TA; Larocque J; Soloveva V; Brown J; Roncarati R J Pharmacol Exp Ther; 2009 Mar; 328(3):766-76. PubMed ID: 19050173 [TBL] [Abstract][Full Text] [Related]
2. Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. Frazier CJ; Rollins YD; Breese CR; Leonard S; Freedman R; Dunwiddie TV J Neurosci; 1998 Feb; 18(4):1187-95. PubMed ID: 9454829 [TBL] [Abstract][Full Text] [Related]
3. Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats. Callahan PM; Terry AV; Tehim A Psychopharmacology (Berl); 2014 Sep; 231(18):3695-706. PubMed ID: 24595504 [TBL] [Abstract][Full Text] [Related]
4. BNC210, a negative allosteric modulator of the alpha 7 nicotinic acetylcholine receptor, demonstrates anxiolytic- and antidepressant-like effects in rodents. O'Connor SM; Sleebs BE; Street IP; Flynn BL; Baell JB; Coles C; Quazi N; Paul D; Poiraud E; Huyard B; Wagner S; Andriambeloson E; de Souza EB Neuropharmacology; 2024 Mar; 246():109836. PubMed ID: 38185416 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Evaluation of Novel Triazine Derivatives as Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors. Wang X; Xiao H; Wang J; Huang Z; Peng G; Xie W; Bian X; Liu H; Shi C; Yang T; Li X; Gao J; Meng Y; Jiang Q; Chen W; Hu F; Wei N; Wang X; Zhang L; Wang K; Sun Q J Med Chem; 2021 Aug; 64(16):12379-12396. PubMed ID: 34374537 [TBL] [Abstract][Full Text] [Related]
8. Allosteric Activation of α7 Nicotinic Acetylcholine Receptors by Novel 2-Arylamino-thiazole-5-carboxylic Acid Amide Derivatives for the Improvement of Cognitive Deficits in Mice. Yang C; Meng Y; Wang X; Li X; Yu T; Liao W; Xie W; Jiang Q; Wang H; Shi C; Jiao W; Bian X; Hu F; Wang X; Liu Y; Zhang L; Wang K; Sun Q J Med Chem; 2024 Apr; 67(8):6344-6364. PubMed ID: 38393821 [TBL] [Abstract][Full Text] [Related]
9. Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor. Olincy A; Freedman R Handb Exp Pharmacol; 2012; (213):211-32. PubMed ID: 23027417 [TBL] [Abstract][Full Text] [Related]
10. Unusual properties of α7 nicotinic acetylcholine receptor ion channels in B lymphocyte-derived SP-2/0 cells. Tarasenko O; Voytenko S; Koval L; Lykhmus O; Kalashnyk O; Skok M Int Immunopharmacol; 2020 Mar; 82():106373. PubMed ID: 32163855 [TBL] [Abstract][Full Text] [Related]
11. Negative and positive allosteric modulators of the α7 nicotinic acetylcholine receptor regulates the ability of adolescent binge alcohol exposure to enhance adult alcohol consumption. Rodd ZA; Swartzwelder HS; Waeiss RA; Soloviov SO; Lahiri DK; Engleman EA; Truitt WA; Bell RL; Hauser SR Front Behav Neurosci; 2022; 16():954319. PubMed ID: 37082421 [No Abstract] [Full Text] [Related]
12. Positive Allosteric Modulators of alpha7 Nicotinic Acetylcholine Receptor for the Treatment of Several Central Nervous System Diseases. Abdel-Magid AF ACS Med Chem Lett; 2024 Jan; 15(1):6-8. PubMed ID: 38229741 [TBL] [Abstract][Full Text] [Related]
13. Correction to 'Hippocampal α7 nicotinic ACh receptors contribute to modulation of depression-like behaviour in C57BL/6J mice'. Br J Pharmacol; 2024 Feb; 181(3):509. PubMed ID: 37994203 [No Abstract] [Full Text] [Related]
14. Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators. Manetti D; Dei S; Arias HR; Braconi L; Gabellini A; Teodori E; Romanelli MN Molecules; 2023 Jan; 28(3):. PubMed ID: 36770942 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic Targeting of Papke RL; Horenstein NA Pharmacol Rev; 2021 Jul; 73(3):1118-1149. PubMed ID: 34301823 [TBL] [Abstract][Full Text] [Related]
16. α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future. Terry AV; Callahan PM Neuropharmacology; 2020 Jun; 170():108053. PubMed ID: 32188568 [TBL] [Abstract][Full Text] [Related]